应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
FBIO Fortress Biotech Inc.
交易中 11-26 14:06:05 EST
1.81
+0.13
+7.44%
最高
1.82
最低
1.70
成交量
35.51万
今开
1.71
昨收
1.68
日振幅
7.14%
总市值
4,983万
流通市值
3,520万
总股本
2,760万
成交额
62.98万
换手率
1.82%
流通股本
1,950万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Fortress Biotech Inc 预计每股亏损59美分 - 财报前瞻
Reuters · 11-13
Fortress Biotech Inc 预计每股亏损59美分 - 财报前瞻
Fortress Biotech Inc 预计每股亏损59美分 - 财报前瞻
路透中文 · 11-08
Fortress Biotech Inc 预计每股亏损59美分 - 财报前瞻
美国食品及药物管理局批准 Journey Medical 用于治疗长期皮肤病的药物
Reuters · 11-04
美国食品及药物管理局批准 Journey Medical 用于治疗长期皮肤病的药物
HC Wainwright & Co.:重申Fortress Biotech(FBIO.US)评级,由买入调整至买入评级, 目标价由24.
智通财经 · 07-20
HC Wainwright & Co.:重申Fortress Biotech(FBIO.US)评级,由买入调整至买入评级, 目标价由24.
暂无数据
公司概况
公司名称:
Fortress Biotech Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Fortress Biotech, Inc.于2006年6月28日在特拉华州注册成立。它是一家涉及新型免疫治疗剂发展的生物制药公司,该药剂用于对自身免疫性疾病和癌症的治疗,包括CNDO-201或是猪鞭虫卵(“TSO”)以及CNDO-109,下面会有充分的描述。作为其发展战略的一部分,公司计划着去识别,评估和潜在的许可,收购或投资于制药和生物技术产品,技术和公司。公司有时也可能会考虑通过合作、合资,直接融资和公共或私人的衍生公司来融资现有的或以后将会收购的产品、技术或公司。
发行价格:
--
{"stockData":{"symbol":"FBIO","market":"US","secType":"STK","nameCN":"Fortress Biotech Inc.","latestPrice":1.805,"timestamp":1732647938921,"preClose":1.68,"halted":0,"volume":355092,"delay":0,"floatShares":19500580,"shares":27604934,"eps":-3.390036,"marketStatus":"交易中","marketStatusCode":2,"change":0.125,"latestTime":"11-26 14:06:05 EST","open":1.71,"high":1.82,"low":1.7001,"amount":629800.9717392,"amplitude":0.071369,"askPrice":1.81,"askSize":7952,"bidPrice":1.8,"bidSize":1231,"shortable":3,"etf":0,"ttmEps":-3.390036,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1732654800000},"adr":0,"adjPreClose":1.68,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":1.71,"preClose":1.68,"latestTime":"09:26 EST","volume":893,"amount":1500.6298838,"timestamp":1732631185595},"postHourTrading":{"tag":"盘后","latestPrice":1.71,"preClose":1.68,"latestTime":"19:20 EST","volume":2438,"amount":4155.1284,"timestamp":1732580419634},"volumeRatio":1.324236,"impliedVol":0.2747,"impliedVolPercentile":0.2648},"requestUrl":"/m/hq/s/FBIO/tweets","defaultTab":"tweets","newsList":[{"id":"2483833862","title":"Fortress Biotech Inc 预计每股亏损59美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2483833862","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483833862?lang=zh_cn&edition=full","pubTime":"2024-11-13 23:52","pubTimestamp":1731513178,"startTime":"0","endTime":"0","summary":" * Fortress Biotech Inc 将于11月15日公布截至2024年9月30日的业绩报告,预计(),季度收入将出现下降。* LSEG 分析师对 Fortress Biotech Inc 的平均预期是每股亏损 59 美分。* 华尔街对 Fortress Biotech Inc 的 12 个月目标价中位数为 13.00 美元,高于其上一次收盘价 1.70 美元。除非另有说明,否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问,请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Fortress Biotech Inc 预计每股亏损59美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBIO"],"gpt_icon":0},{"id":"2481400483","title":"Fortress Biotech Inc 预计每股亏损59美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481400483","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481400483?lang=zh_cn&edition=full","pubTime":"2024-11-08 23:52","pubTimestamp":1731081122,"startTime":"0","endTime":"0","summary":"Fortress Biotech Inc 预计每股亏损59美分 - 财报前瞻Fortress Biotech Inc FBIO.OQ FBIO.O预计将在11月12日公布截至0001年1月1日的业绩报告(估计),季度收入将出现下降。LSEG 分析师对 Fortress Biotech Inc 的平均预期是每股亏损 59 美分。华尔街对 Fortress Biotech Inc 的 12 个月目标价中位数为 13.00 美元,高于其最新收盘价 1.72 美元。11月8日 - 以前季度业绩。除非另有说明,否则所有数据均以美元为单位。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241108:nL4S3MF1SI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBIO"],"gpt_icon":0},{"id":"2480030174","title":"美国食品及药物管理局批准 Journey Medical 用于治疗长期皮肤病的药物","url":"https://stock-news.laohu8.com/highlight/detail?id=2480030174","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480030174?lang=zh_cn&edition=full","pubTime":"2024-11-04 20:09","pubTimestamp":1730722152,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 路透11月4日 - Journey Medical公司周一表示,美国食品和药物管理局已批准该公司生产的 药物用于治疗一种名为酒渣鼻的长期皮肤病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","DERM","FBIO","BK4007"],"gpt_icon":0},{"id":"2452404939","title":"HC Wainwright & Co.:重申Fortress Biotech(FBIO.US)评级,由买入调整至买入评级, 目标价由24.","url":"https://stock-news.laohu8.com/highlight/detail?id=2452404939","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452404939?lang=zh_cn&edition=full","pubTime":"2024-07-20 01:49","pubTimestamp":1721411359,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["FBIO","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.fortressbiotech.com","stockEarnings":[{"period":"1week","weight":0.1351},{"period":"1month","weight":-0.0919},{"period":"3month","weight":-0.1805},{"period":"6month","weight":-0.0769},{"period":"1year","weight":-0.2364},{"period":"ytd","weight":-0.4419}],"compareEarnings":[{"period":"1week","weight":0.0159},{"period":"1month","weight":0.0319},{"period":"3month","weight":0.0641},{"period":"6month","weight":0.1358},{"period":"1year","weight":0.3124},{"period":"ytd","weight":0.2571}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Fortress Biotech, Inc.于2006年6月28日在特拉华州注册成立。它是一家涉及新型免疫治疗剂发展的生物制药公司,该药剂用于对自身免疫性疾病和癌症的治疗,包括CNDO-201或是猪鞭虫卵(“TSO”)以及CNDO-109,下面会有充分的描述。作为其发展战略的一部分,公司计划着去识别,评估和潜在的许可,收购或投资于制药和生物技术产品,技术和公司。公司有时也可能会考虑通过合作、合资,直接融资和公共或私人的衍生公司来融资现有的或以后将会收购的产品、技术或公司。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":0.108956},{"month":2,"riseRate":0.666667,"avgChangeRate":0.02724},{"month":3,"riseRate":0.444444,"avgChangeRate":-0.009777},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.022071},{"month":5,"riseRate":0.4,"avgChangeRate":-0.034317},{"month":6,"riseRate":0.3,"avgChangeRate":-0.019274},{"month":7,"riseRate":0.6,"avgChangeRate":-0.008441},{"month":8,"riseRate":0.5,"avgChangeRate":0.024506},{"month":9,"riseRate":0.2,"avgChangeRate":-0.106031},{"month":10,"riseRate":0.3,"avgChangeRate":-0.149116},{"month":11,"riseRate":0.7,"avgChangeRate":0.092255},{"month":12,"riseRate":0.555556,"avgChangeRate":0.065807}],"exchange":"NASDAQ","name":"Fortress Biotech Inc.","nameEN":"Fortress Biotech"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Fortress Biotech Inc.(FBIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Fortress Biotech Inc.(FBIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Fortress Biotech Inc.,FBIO,Fortress Biotech Inc.股票,Fortress Biotech Inc.股票老虎,Fortress Biotech Inc.股票老虎国际,Fortress Biotech Inc.行情,Fortress Biotech Inc.股票行情,Fortress Biotech Inc.股价,Fortress Biotech Inc.股市,Fortress Biotech Inc.股票价格,Fortress Biotech Inc.股票交易,Fortress Biotech Inc.股票购买,Fortress Biotech Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Fortress Biotech Inc.(FBIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Fortress Biotech Inc.(FBIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}